Dr. G: Medical Examiner

G Medical Innovations Will Provide Services to Veterans and Military Personnel by Partnering With Resilient Support Services

Retrieved on: 
Thursday, August 17, 2023
Dr. G: Medical Examiner, Communication, RSS, Lieutenant colonel, Veteran, Military personnel, Patient, RPM, Hospital, Management

Rehovot, Israel, Aug. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations”), an industry innovator in comprehensive remote patient monitoring solutions, today announced that its wholly-owned subsidiary, G Medical Innovations USA, Inc., has entered into an agreement with Resilient Support Services Inc. (“RSS”) to expand the health care and remote patient monitoring capabilities to U.S. veterans and military personnel.

Key Points: 
  • Rehovot, Israel, Aug. 17, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations”), an industry innovator in comprehensive remote patient monitoring solutions, today announced that its wholly-owned subsidiary, G Medical Innovations USA, Inc., has entered into an agreement with Resilient Support Services Inc. (“RSS”) to expand the health care and remote patient monitoring capabilities to U.S. veterans and military personnel.
  • G Medical Innovations’ innovative technology will help federal agencies and military personnel to better monitor and diagnose new onset cardiovascular symptoms as part of a growing need in virtual care.
  • This will allow full access to near real-time patient information which will also be analyzed by certified cardiac monitoring technicians through G Medical Innovations’ own independent diagnostic testing facility.
  • “We are excited to have G Medical Innovations provide their powerful technology and 31 test kits to those serving our country in veteran affairs and all military branches here and abroad.

G Medical Innovations’ CEO Issues Update to Shareholders, August 2023

Retrieved on: 
Monday, August 7, 2023
Blood pressure, HTK, Dr. G: Medical Examiner, Workforce, Software as a service, Limitless, Marketing, EVP, Sleep, Sleep apnea, RHM, AdventHealth, HTK Ltd, CLIA, Healthcare Facilities Accreditation Program, Hospital, MHealth, Patient, Physician, Sleep disorder, Algorithm, Corporation, Memorial Hermann Health System, Vertically transmitted infection, Amazon Marketplace, Growth, R, CFO, Conditional sentence, Software, Management, Food delivery, Pharmaceutical industry, Central Florida, Amazon, Prizma

Rehovot, Israel, Aug. 07, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations” or the “Company”), a global leader in next-generation mobile health (mHealth) and digital health, today issued the following update to shareholders from President and CEO Dr. Yacov Geva.

Key Points: 
  • Rehovot, Israel, Aug. 07, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical Innovations” or the “Company”), a global leader in next-generation mobile health (mHealth) and digital health, today issued the following update to shareholders from President and CEO Dr. Yacov Geva.
  • We are proud to report that at this halfway point of 2023, G Medical has met several significant milestones and is on track to show revenue growth and gain profitability.
  • We plan to launch this service during the 4th quarter of 2023 and we are already in discussions with hospitals.
  • Our management team is razor focused on increasing revenue during 2023 and we are looking forward to an even brighter 2024 and beyond.

G MEDICAL UPDATES ON PATIENT ENROLLMENT GROWTH FOR ITS HOME MONITORING SERVICES OF 194% FROM JANUARY THROUGH APRIL 2023, AS COMPARED TO THE SAME PERIOD IN 2022

Retrieved on: 
Tuesday, April 18, 2023
Central Florida, Dr. G: Medical Examiner, Medicine, RTM, Urine, Privacy, AdventHealth, MHealth, Hospital, Patient, Physician, RPM, Saliva, Pharmaceutical industry, Food delivery, Medical device

As previously announced, in the first quarter of 2023, G Medical signed an agreement with AdventHealth of Central Florida (“AdventHealth”), an operator of 20 hospitals and emergency rooms.

Key Points: 
  • As previously announced, in the first quarter of 2023, G Medical signed an agreement with AdventHealth of Central Florida (“AdventHealth”), an operator of 20 hospitals and emergency rooms.
  • G Medical also recently signed an agreement with MiCare Path to integrate MiCare Path’s software platform and visualization tools to its devices.
  • The G Medical collaboration will allow for a total remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) solution from service to exceptional future solutions.
  • G Medical expects that in the third quarter of 2023 consumers will be able to purchase these kits at retail stores or via online purchase.

G MEDICAL INNOVATIONS AND MICARE PATH ANNOUNCE JOINT COLLABORATION TO PROVIDE INNOVATIVE REMOTE PATIENT MONITORING SOLUTIONS GLOBALLY

Retrieved on: 
Monday, March 27, 2023
Dr. G: Medical Examiner, Communication, Partnership, RTM, Information technology, Patient, MHealth, Physician, RPM, Health, Medical device

Rehovot, Israel, March 27, 2023 (GLOBE NEWSWIRE) --  G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”), a global leader in next-generation mobile health (mHealth) and digital health, and MiCare Path, a leader in optimized patient care through remote patient monitoring, today announced a collaboration to incorporate MiCare Path’s solutions and G Medical Innovations’ solutions.

Key Points: 
  • Rehovot, Israel, March 27, 2023 (GLOBE NEWSWIRE) --  G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”), a global leader in next-generation mobile health (mHealth) and digital health, and MiCare Path, a leader in optimized patient care through remote patient monitoring, today announced a collaboration to incorporate MiCare Path’s solutions and G Medical Innovations’ solutions.
  • As part of the collaboration, G Medical Innovations’ hardware devices will be integrated with MiCare’s software platform and visualization tools to provide remote patient monitoring services.
  • G Medical Innovations was a chosen partner for MiCare Path due to its innovative and scalable solution for building and fostering health technology.
  • “The G Medical collaboration will allow for a total remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) solution from service to exceptional future solutions.”

G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.

Retrieved on: 
Monday, December 5, 2022
Degenerative disease, Cardiovascular disease, Temperature, Light, Reading, Patent, Algorithm, Pressure, Diabetes, CVD, Telehealth, Short QT syndrome, Dr. G: Medical Examiner, Software patents under United States patent law, Smartphone, Vital signs, MHealth, Patient, Medical device, Prizma

This patent integrates sensing mechanism that allows the monitoring system to analyze the sensing condition (pressure, ambient temperature, light, conductivity, etc.)

Key Points: 
  • This patent integrates sensing mechanism that allows the monitoring system to analyze the sensing condition (pressure, ambient temperature, light, conductivity, etc.)
  • This allows higher and more accurate sensing that results in reducing false positive reading including false alarms.
  • This will allow the company to increase the attractiveness of its products, boost its market activity and achieve a bigger market share.
  • G Medical Innovations Holdings Ltd. is a healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of G Medical Holdings Ltd - GMVD

Retrieved on: 
Tuesday, November 29, 2022
IPO, Calendar, Dr. G: Medical Examiner, Private investigator

NEW YORK, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of G Medical Holdings Ltd (G Medical or the Company) (NASDAQ:GMVD).

Key Points: 
  • NEW YORK, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of G Medical Holdings Ltd (G Medical or the Company) (NASDAQ:GMVD).
  • The investigation concerns whether G Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On or around June 24, 2021, G Medical conducted its initial public offering (IPO), issuing 3 million shares priced at $5.00.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

G Medical Innovations Announces First Half 2022 Financial Results and Provides Business Update

Retrieved on: 
Friday, November 18, 2022
COVID-19, Growth, Degenerative disease, Short QT syndrome, Patient, Cardiovascular disease, Government, Electrocardiography, Vital signs, Annual report, Telehealth, Research, Diabetes, PCR, Security (finance), Prizma, Special-purpose acquisition company, MHealth, Risk, Smartphone, Collection, Dr. G: Medical Examiner, Animal, Life insurance, Medical device, Rope

Irvine, CA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (G Medical or the Company), an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms, today announced its financial results and provided a business update for the six months ended June 30, 2022.

Key Points: 
  • Irvine, CA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (G Medical or the Company), an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms, today announced its financial results and provided a business update for the six months ended June 30, 2022.
  • Cash and cash equivalents as of June 30, 2022, were $1,509 thousand, compared to $6,034 thousand as of December 31, 2021.
  • About G Medical Innovations Holdings Ltd.
    G Medical Innovations Holdings Ltd. is an early commercial stage healthcare company engaged in the development of next generation mHealth and telemedicine solutions and monitoring service platforms.
  • The Companys actual results and financial condition may differ materially from those indicated in the forward-looking statements.

G Medical Innovations is introducing a Monkeypox consumer home health test kit, along with 30 new direct to consumer home health testing kits with 24 to 48 hours results

Retrieved on: 
Thursday, October 6, 2022
MHealth, Short QT syndrome, CLIA, Cardiovascular disease, Pharmacy, Smartphone, Patient, Privacy, Dr. G: Medical Examiner, Private Securities Litigation Reform Act, Degenerative disease, Company, Saliva, CEO, CVD, Diabetes, Telehealth, Vital signs, Solution, Algorithm, Medical device, Prizma

IRVINE, California, Oct. 06, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that its wholly owned subsidiary, G. Medical Health and Wellness, Inc., has developed 31 different at-home health tests kits that are expected to be available to consumers during Q4-2022 through online and later popular big-box retail sites and pharmacies across the United States.

Key Points: 
  • Consumers should expect to pay anywhere from$50to$260depending on the tests complexity.
  • As telehealth and telemedicine industry pioneers, the management ofG Medical Innovationshas been offering patient home care monitoring and service for over 30 years.
  • G Medical Innovations Holdings Ltd.is a healthcare company engaged in the development of next-generation mHealth and telemedicine solutions and monitoring service platforms.
  • References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results

Retrieved on: 
Wednesday, July 13, 2022
Online, Telehealth, Security (finance), U.S. Securities and Exchange Commission, Pharmacy, Dr. G: Medical Examiner, Privacy, Solution, Diabetes, Food, Vital signs, Company, Wellness, CLIA, Patient, CEO, Algorithm, GLOBE, Cardiovascular disease, MHealth, Private Securities Litigation Reform Act, Glycated hemoglobin, CVD, Short QT syndrome, Smartphone, Saliva, Degenerative disease, HPV, NASDAQ, Medical device, Prizma

IRVINE, Calif., July 13, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that its wholly owned subsidiary, G. Medical Health and Wellness, Inc., has developed seven different at-home tests that are expected to be available to consumers during Q3-2022 through popular big-box retail sites, pharmacies and Online. The tests developed for health issues ranging from food sensitivity, Indoor/Outdoor allergies, HPV, thyroid functioning, testosterone levels, and the hemoglobin A1C test, with results going directly to the user within days.

Key Points: 
  • The tests developed for health issues ranging from food sensitivity, Indoor/Outdoor allergies, HPV, thyroid functioning, testosterone levels, and the hemoglobin A1C test, with results going directly to the user within days.
  • This will allow them to quickly begin making any necessary health changes or follow up health care visits, said Dr. Yacov Geva, CEO of G Medical Innovations.
  • As Telehealth and Telemedicine industry pioneers, the management of G Medical Innovations has been offering patient home care monitoring and service for over 30 years.
  • G Medical Innovations Holdings Ltd. is a healthcare company engaged in the development of next-generation mHealth and telemedicine solutions and monitoring service platforms.

IMPROVATE held two-day medical innovation and networking conference in Budapest, sparking groundbreaking deals between European representatives and leading Israeli medical technology companies

Retrieved on: 
Wednesday, April 27, 2022
Clalit Health Services, Robotics, HLS, Hospital, List of Medknow Publications academic journals, Weizmann Institute of Science, Patient, Technology, Acute kidney injury, Category:Medwell Journals academic journals, Health, Knowledge, COVID-19, MHealth, Person-centered therapy, Sterilization, Medicine, Synergy, Cardiology, Meir Hospital, Solution, PSIS, Partnership, CEO, Sheba Medical Center, State, Sleep apnea, Tel HaShomer, Dr. G: Medical Examiner, Tissue, TEL, Surgeon, Food, Hadassah Medical Center, HMO, Transformation, Emergency Medical Treatment and Active Labor Act, Martinsburg Mining, Manufacturing & Improvement Co. Historic District, VC, ALTA, Pharmacy, Innovation, 3D, Alta, Critical care, Coat of arms of the Romanian Ministry of Internal Affairs, Risk, Mobile phone, 3D printing, Pharmaceutical industry

TEL AVIV, Israel, April 27, 2022 /PRNewswire/ -- IMPROVATE, a platform for connecting change-makers and decision-makers, held a two-day medical innovation conference and business meet-up in Budapest, Hungary, with the participation of speakers and representatives from countries across Central and Eastern Europe, including several former presidents and prime ministers.

Key Points: 
  • Following the event, several business deals have already been initiated between European representatives and Israeli medical technology companies:
    GMedical , which develops health monitoring systems, is in talks with a European network of hospitals that also participated in the conference.
  • In addition, several other contacts between companies presenting at the conference and attending institutions are expected to mature into deals.
  • The second day of the event was devoted to business networking between Israeli technology companies participating in the conference, and hospital directors, medical distributors, and buyers from across the region.
  • Leading Israeli medical technology companies presented at the event: G-Medical, RenalSense , IGIN Smart, Appscent, Synergy 3d-Med, ALTA Medical , NeoPharm Israel , and Tuttenauer .